Conexeu Sciences is trading 5.31% down at $2.40, with the decline consistent with biotechnology sector pressure.
- Biotechnology stocks are down 2.39% during the regular session. Major market indices are higher, so broad-market weakness does not appear to explain the move.
- No company-specific announcement explaining the November 2 move was identified; the latest reported company news was an October 15 private placement.